'Mix and Match' COVID-19 study finds Pfizer or Moderna boosters may be best for J&J vaccine

'Mix and Match' COVID-19 study finds Pfizer or Moderna boosters may be best for J&J vaccine

'Mix and Match' COVID-19 study finds Pfizer or Moderna boosters may be best for J&J vaccine - The National Institutes of Health study found that the J&J shot followed by one of the mRNA vaccines as a booster produced a stronger immune response than two doses of J&J. - In response to the study, Johnson & Johnson noted that a booster of its vaccine increased the immune response regardless of a person's previous primary vaccination. - The FDA's Vaccines and Related Biological Products Advisory Committee meets Thursday to discuss Moderna boosters and Friday to discuss J&J boosters. The best booster for the Johnson & Johnson COVID-19 vaccine may be either Pfizer-BioNTech or Moderna, according to a National Institutes of Health study posted Wednesday. "The Mix and Match was a big …
More on: www.usatoday.com